Literature DB >> 10381663

Early retreatment of infantile esotropia: comparison of reoperation and botulinum toxin.

J Tejedor1, J M Rodríguez.   

Abstract

AIM: To compare the efficacy of reoperation and botulinum toxin injection in treating infantile esotropes early after unsatisfactory surgical alignment.
METHODS: 55 strabismic children who had been unsuccessfully operated for infantile esotropia were randomised to reoperation (28 patients) or botulinum toxin injection (27 patients). The motor outcomes (percentage of successful motor outcome and percentage change in deviation) were compared at 6 months, 1 year, and 3 years after retreatment, and the sensory outcomes (percentage with fusion ability and stereo perception) at the 3 year follow up visit.
RESULTS: The motor and sensory outcomes and the stability of motor results were similar in patients reoperated and treated with botulinum injection. At the 3 year visit 67.8% and 59.2% of children were, respectively, within 8 prism dioptres of orthotropia (p=0.72). The frequency of fusion ability was, respectively, 60.7% and 51.8% (p=0.71), and the frequency of stereo perception (</=400 seconds of arc, Randot circles), 57.1% and 48.1% (p=0.70). The botulinum injection was more likely to be effective when carried out in the 6 months following initial surgery.
CONCLUSIONS: Botulinum injection is a rapid and less invasive alternative to reoperation in children who have been unsuccessfully treated with surgery to correct infantile esotropia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381663      PMCID: PMC1723128          DOI: 10.1136/bjo.83.7.783

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Characteristics of recession-resection and bimedial recession for childhood esotropia.

Authors:  G B Bartley; J A Dyer; D M Ilstrup
Journal:  Arch Ophthalmol       Date:  1985-02

2.  Surgery for large-angle congenital esotropia. Two vs three and four horizontal muscles.

Authors:  W E Scott; P D Reese; C R Hirsh; C A Flabetich
Journal:  Arch Ophthalmol       Date:  1986-03

3.  A randomized comparison of surgical procedures for infantile esotropia.

Authors:  B J Kushner; G V Morton
Journal:  Am J Ophthalmol       Date:  1984-07-15       Impact factor: 5.258

4.  Early surgery for congenital esotropia.

Authors:  M Ing; F D Costenbader; M M Parks; D G Albert
Journal:  Am J Ophthalmol       Date:  1966-06       Impact factor: 5.258

5.  Early surgical alignment for congenital esotropia.

Authors:  M R Ing
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

6.  Surgical treatment of congenital esotropia.

Authors:  E M Helveston; F D Ellis; J Schott; J Mitchelson; J C Weber; S Taube; K Miller
Journal:  Am J Ophthalmol       Date:  1983-08       Impact factor: 5.258

7.  Retreatment of children after surgery for acquired esotropia: reoperation versus botulinum injection.

Authors:  J Tejedor; J M Rodríguez
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

8.  Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm.

Authors:  C L Burns; J A Gammon; M C Gemmill
Journal:  Ophthalmology       Date:  1986-12       Impact factor: 12.079

9.  Sequelae of botulinum toxin injection.

Authors:  R W Lingua
Journal:  Am J Ophthalmol       Date:  1985-08-15       Impact factor: 5.258

10.  Reoperations in esotropia surgery.

Authors:  W T Kittleman; M L Mazow
Journal:  Ann Ophthalmol       Date:  1986-05
View more
  10 in total

Review 1.  [Use of botulinum toxin in strabismus].

Authors:  B Wabbels
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

2.  Use of Botulinum Toxin in Ophthalmology.

Authors:  Michael J Wan; Sara AlShaker; David G Hunter
Journal:  Handb Exp Pharmacol       Date:  2021

3.  The efficacy of botulinum toxin treatment for children with a persistent esotropia following bilateral medial rectus recessions and lateral rectus resections.

Authors:  Scott R Lambert; Marla J Shainberg
Journal:  Am Orthopt J       Date:  2013

4.  Rates of Reoperation and Abnormal Binocularity Following Strabismus Surgery in Children.

Authors:  Christopher T Leffler; Kamyar Vaziri; Stephen G Schwartz; Kara M Cavuoto; Craig A McKeown; Krishna S Kishor; Adam C Janot
Journal:  Am J Ophthalmol       Date:  2015-11-05       Impact factor: 5.258

Review 5.  Botulinum toxin for the treatment of strabismus.

Authors:  Fiona J Rowe; Carmel P Noonan
Journal:  Cochrane Database Syst Rev       Date:  2017-03-02

6.  Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics.

Authors:  Li-Juan Lang; Yu Zhu; Zhi-Gang Li; Guang-Ying Zheng; Hai-Ying Peng; Jun-Bo Rong; Li-Min Xu
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

7.  Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons.

Authors:  Charles Joussain; Olivier Le Coz; Andrey Pichugin; Peggy Marconi; Filip Lim; Mariaconcetta Sicurella; Andrea Salonia; Francesco Montorsi; Francisco Wandosell; Keith Foster; François Giuliano; Alberto L Epstein; Alejandro Aranda Muñoz
Journal:  Toxins (Basel)       Date:  2019-02-19       Impact factor: 4.546

8.  Short-term outcome of botulinum neurotoxin A injection with or without sodium hyaluronate in the treatment of infantile esotropia-a prospective interventional study.

Authors:  Nitika Pandey; Siddharth Agrawal; Rajat M Srivastava; Vinita Singh
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

9.  The Efficacy of Dose Increments of Botulinum Toxin A in the Treatment of Childhood Esotropia.

Authors:  Fatemah T Alshamlan; Halla A Al Abdulhadi; Mofi M Alwalmany; Khalid S Alotaibi
Journal:  Clin Ophthalmol       Date:  2021-01-12

10.  Botulinum toxin chemodenervation for childhood strabismus in England: National and local patterns of practice.

Authors:  Ameenat Lola Solebo; Anne-Marie Austin; Maria Theodorou; Chris Timms; Joanne Hancox; Gillian G W Adams
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.